Big Pharma Split Corp. (PRM)

Profile

https://www.harvestportfolios.com/closed-end-funds/big-pharma-split-corp/

Big Pharma Split Corp. is a specialized investment corporation focused on providing investors with exposure to large pharmaceutical companies. Its primary function is to invest in a diversified portfolio of prominent pharmaceutical firms, offering both capital appreciation and dividend income. The corporation typically engages in the acquisition and management of equity securities within the global pharmaceutical sector, targeting major players that are essential to healthcare advancement, drug development, and biotechnology research. The notable features of Big Pharma Split Corp. include its structured approach that involves splitting its investment capital into two distinct classes of shares—classifying them often as capital and preferred shares. This dual-share structure is designed to cater to different investor preferences, with an emphasis on balancing growth potential and income stability. In the financial market, Big Pharma Split Corp. serves as a pivotal instrument for investors seeking targeted exposure to the healthcare sector, particularly those focusing on the rapid innovation and expansion characteristic of the pharmaceutical industry. By leveraging its assets effectively, the corporation contributes to the broader goals of drug innovation and public access to healthcare solutions.